510(k) K133936

Device
ARTUS C. DIFFICILE QS-RGQ MDX KIT
Applicant
QIAGEN, GMBH
510(k) number
K133936
Product code
OZN  
Decision
Substantially Equivalent (SESE)
Decision date
2014-04-04
Date received
2013-12-23
Regulation
866.3130
Classification name
C. Difficile Toxin Gene Amplification Assay
Medical specialty
Microbiology
Review panel
Microbiology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
Kimberly Mapp
Address
1201 Clopper Rd. Gaithersburg MD US 20878 20878

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code OZN  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K243730Xpert C. difficile/EpiCepheid®2025-02-28
K232092Great Basin Toxigenic C. difficile Direct Test (CDF2)Vela Operations USA2023-11-14
K212427cobas Cdiff nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2021-10-20
K210385cobas Cdiff nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2021-09-09
K172569GenePOC CDiffGenepoc, Inc.2017-11-22
K171770cobas Cdiff Nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2017-09-12
K171441ARIES C. difficile Assay Complete Kit, ARIES C. difficile Assay Protocol File Kit, ARIES C. difficile Assay Kit (24 cassettes), ARIES Stool Resuspension KitLuminex Corporation2017-07-21
K170491Solana C. difficile AssayQuidel Corporation2017-05-11
K163085Simplexa C. difficile Direct; Simplexa C. difficile Positive Control PackFocus Diagnostics, Inc.:Dba Diasorin Molecular, LLC2017-02-14
K142422cobas Cdiff TestRoche Molecular Systems, Inc.2015-05-20
K132726ICEPLEX C. DIFFICILE ASSAY KIT, ICEPLEX SYSTEMPrimeradx2013-11-29
K132235IMDX C.DIFFICILE FOR ABBOTT M2000Intelligent Medical Devices, Inc.2013-10-11
K130470BD MAX CDIFF ASSAY, BD MAX INSTRUMENTGeneohm Sciences Canada, Inc. (Bd Diagnostics)2013-04-02
K123998QUIDEL MOLECULAR DIRECT C. DIFFICILE ASSAYQuidel Corp.2013-03-08
K123355AMPLIVUE C. DIFFICILE ASSAYQuidel Corporation2012-12-13

Legacy Summary#

summary

FDA Review#

Decision Summary